Table 4. Summary of outcomes and comparisons where relevant.
| Author and publication year | Study period/timing of outcome | Model | Acceptability | Blood sugar level* | Linkage and engagement in care | |||
|---|---|---|---|---|---|---|---|---|
| Model outcome | Conventional care outcome | Model outcome | Conventional care outcome | Model outcome | Conventional care outcome | |||
| Pastakia et al. 2017 [38] | 6 to 12 months | Community-initiated | - | FBS: 160.4mg/dl at baseline; 153.2mg/dl after 6 months. HbA1c: 10.8% at baseline; 10.0% after 6 months |
- | 100% 10/10 with T2DM linked to care 70% engagement in care at 9 months |
31% linkage to care | |
| Takenga et al. 2014 [39] | 2 months | eHealth | For patients: Mean score of 8.65 on a scale of 1 to 10. For medical staff: Mean score of 8.75 |
- | HbA1c: 8.65% at baseline; 6.89% at 2 months |
HbA1c: 8.59% at baseline; 8.6% at 2 months | - | - |
| Ndou et al. 2013 [21] | NR | Facility-originated community model | - | - | FBS 3.6–5.8 mmol/L: 9.1% |
FBS 3.6–5.8mmol/L: 26.1% | - | - |
| David et al. 2022 [37] | 16 months | Facility-originated community model | 100% acceptability of model | - | HbA1c: 9.3% at baseline; 9.5% at follow-up 28% of patients with controlled# DM at baseline; 27% of patients with controlled DM at follow-up |
HbA1c: 9.6% at baseline; 10.1% at follow-up 27% of patients with controlled DM at baseline; 22% of patients with controlled DM at follow-up |
||
NR = not reported; FBS = fasting blood sugar; HbA1c = glycated haemoglobin. * Reported FBS and HbA1c values are averages.
# Controlled DM for the intervention was defined as HbA1c < 7.5%